BridgeBio Oncology Therapeutics is a clinical-stage company focused on drug discovery and development targeting the RAS signaling pathway in cancer. The company aims to create novel RAS-targeted small molecules for patients with lethal cancers.
investor of
Metrics
marketPRIVATE
msh_idCOM:BRIDGEBIOONCOLOGY
localeus
websitehttps://bridgebiooncology.com
source_reff12777a8-cb35-4684-9474-5bde0a126b68
products_or_servicesDrug discovery and development targeting RAS for cancer treatment.
United States